Microbot Medical Inc. (MBOT) announced Thursday the successful completion of its GLP pivotal pre-clinical study, done under the guidelines of FDA-required levels of planning, controlling, monitoring, and reporting, using a porcine model.
Microbot Medical Inc. (MBOT), a pre-clinical medical device company, gained 47% after announcement of positive results from its GLP pivotal pre-clinical study of Liberty Endovascular Robotic Surgical system.